Recent research published in the Proceedings of the National Academy of Sciences (PNAS) has uncovered alarming effects of the anti-aging drug combination dasatinib and quercetin (D+Q) in mice. The study found that D+Q leads to significant loss of myelin, the protective sheath surrounding nerve fibers, which is essential for proper nerve function. This damage was particularly pronounced in younger mice, raising concerns about the safety of these compounds in anti-aging therapies. The researchers observed that the corpus callosum, a critical brain structure connecting different brain regions, essentially disappeared following treatment. Interestingly, the myelin-producing cells did not die but reverted to a more immature state, which may open avenues for potential recovery strategies in conditions like multiple sclerosis (MS). This research highlights the dual nature of D+Q, presenting both risks and potential therapeutic insights for neurodegenerative diseases.